Accès au site français Welcome to You buy France The french suppliers portal


twitter linkedin facebook viadeo

You buy France


Activity Presentation
Poxel is a biopharmaceutical company developing innovative first-in-class drugs with a primary focus on Type 2 diabetes. The company develops drug candidates to clinical proof of concept before partnering with pharmaceutical companies. Poxel operates independently as a lean organization with strong in-house drug development expertise.
Its pipeline consists in innovative projects with new mechanisms of action, with an activity on glucose metabolism, other cardiovascular risk factors and with an improved safety profile compared to currently available therapies.

Key features of the company
• Imeglimin, 1st-in-class oral antidiabetic agent, having already achieved its clinical proof of concept. Excellent benefit/risk ratio.
• 5 other innovative programs in early stage development
• Strong IP position
• Seasoned team of executives coming from the Pharma Industry
• Network of re-known international key opinion leaders, experts and suppliers

+ Read more


Company profile

Related activities :

Health, pharmacy, life sciences

Export area :

European Union

North America

North Asia

Local presence :

European Union

Target countries :

European Union

North America

North Asia

More information










Business France contributes to the development and success of French and foreign businesses wishing to expand abroad by supporting them throughout the lifetime of their projects, and is driven by an efficient, result-oriented working culture. > Read more


Discover the French know how:



Rail industry